<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Biallelic protein-truncating mutations in the <z:mpath ids='MPATH_271'>adenomatous polyposis coli</z:mpath> (APC) gene are prevalent in <z:hpo ids='HP_0003745'>sporadic</z:hpo> <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>Mutations may not be fully inactivating, instead producing WNT/β-catenin signalling levels 'just-right' for <z:e sem="disease" ids="C1326912" disease_type="Neoplastic Process" abbrv="">tumourigenesis</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>However, the spectrum of optimal APC genotypes accounting for both hits, and the influence of clinicopathological features on genotype selection remain undefined </plain></SENT>
<SENT sid="3" pm="."><plain>We analysed 630 <z:hpo ids='HP_0003745'>sporadic</z:hpo> <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRCs</z:e> for APC mutations and loss of heterozygosity (LOH) using sequencing and single-nucleotide polymorphism microarrays, respectively </plain></SENT>
<SENT sid="4" pm="."><plain>Truncating APC mutations and/or LOH were detected in 75% of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRCs</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>Most truncating mutations occurred within a mutation cluster region (MCR; codons 1282-1581) leaving 1-3 intact 20 amino-acid repeats (20AARs) and abolishing <z:hpo ids='HP_0000001'>all</z:hpo> Ser-Ala-Met-Pro (SAMP) repeats </plain></SENT>
<SENT sid="6" pm="."><plain><z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">Cancers</z:e> commonly had one MCR mutation plus either LOH or another mutation 5' to the MCR </plain></SENT>
<SENT sid="7" pm="."><plain>LOH was associated with mutations leaving 1 intact 20AAR </plain></SENT>
<SENT sid="8" pm="."><plain>MCR mutations leaving 1 vs 2-3 intact 20AARs were associated with 5' mutations disrupting or leaving intact the armadillo-repeat domain, respectively </plain></SENT>
<SENT sid="9" pm="."><plain><z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">Cancers</z:e> with three hits had an over-representation of mutations upstream of codon 184, in the alternatively spliced region of exon 9, and 3' to the MCR </plain></SENT>
<SENT sid="10" pm="."><plain>Microsatellite unstable <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> showed hyper-mutation at MCR mono- and di-nucleotide repeats, leaving 2-3 intact 20AARs </plain></SENT>
<SENT sid="11" pm="."><plain>Proximal and distal <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> exhibited different preferred APC genotypes, leaving a total of 2 or 3 and 0 to 2 intact 20AARs, respectively </plain></SENT>
<SENT sid="12" pm="."><plain>In conclusion, APC genotypes in <z:hpo ids='HP_0003745'>sporadic</z:hpo> <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRCs</z:e> demonstrate 'fine-tuned' interdependence of hits by type and location, consistent with selection for particular residual levels of WNT/β-catenin signalling, with different 'optimal' thresholds for proximal and distal <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e>.Oncogene advance online publication, 22 October 2012; doi:10.1038/onc.2012.486 </plain></SENT>
</text></document>